Evidence map›Paper›PMID 40003366›Full record

ReviewInternational journal of environmental research and public health2025

Chronic Kidney Disease in Balkan Countries-A Call for Optimal Multidisciplinary Management.

Mario Laganović, Radomir Naumović, Milena Nikolova, Petar Petrov, Josipa Radić, Igor Mitić, Andreja Marn Pernat

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mario LaganovićDepartment of Nephrology, Clinical Hospital Merkur, 10000 Zagreb, Croatia.
Radomir NaumovićClinic of Nephrology, Zvezdara University Clinical Hospital, 11000 Belgrade, Serbia.ORCID 0000-0002-5520-2326
Milena NikolovaClinic of Nephrology, University Hospital "St Ivan Rilski", 1000 Sofia, Bulgaria.
Petar PetrovClinic of Nephrology, University Hospital St. Marina, 9010 Varna, Bulgaria.
Josipa RadićDepartment of Nephrology, University Hospital Centre Split, School of Medicine, University of Split, 21000 Split, Croatia.ORCID 0000-0003-2645-7597
Igor MitićClinic for Nephrology and Clinical Immunology, University Clinical Center of Vojvodina, 21000 Novi Sad, Serbia.
Andreja Marn PernatMedical Faculty, University of Ljubljana, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of chronic kidney disease (CKD) has been considerably transformed in the last couple of years. However, effective management of patients with CKD is still not achieved, despite clear guidelines promoting active screening of high-risk patients, immediate diagnosis based on laboratory markers, and early initiation or intensification of pharmacotherapy like sodium/glucose cotransporter 2 (SGLT2) inhibitors, which showed reliable results in preventing disease progression, complications, and mortality. Following a recent initiative on early diagnosis, nephrology experts from Bulgaria, Croatia, Serbia, and Slovenia discussed the challenges and opportunities related to CKD treatment in the Balkan countries, also reflecting on the heterogenous socio-economic context of the region. The ongoing education of all stakeholders involved in kidney care, structured support for primary care providers, and the improvement of multidisciplinary networks were consistently recognized as key success factors. Optimal CKD management is based on continuity of care and the timely transition of coordination from primary care to nephrology-specialized services.

Indexed as

Renal Insufficiency, ChronicBalkan PeninsulaHumansBalkanchronic kidney diseaseCKDEastern EuropeSGLT2 inhibitortreatment

Identifiers

PMID40003366
PMCPMC11855889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.